Bloodstream Infection Testing Market Trends

Growth Drivers

• Growing government initiatives and increasing awareness about blood donation - Regular blood donation by a sufficient number of healthy people can save a life, or even several if the blood is separated into its components. According to WHO, around 118.5 million blood donations are collected across the world, and 40% of these are collected in high-income countries, home to 16% of the world’s population.
  WHO strongly recommended that it should be compulsory to screen all blood donations for various infections before using them. This screening includes HIV, hepatitis B, and syphilis and should stick to the need for a quality system. Moreover, there is a growing demand for advanced screening technologies and solutions to effectively identify potential infections in donated blood.
• Creating awareness about healthcare-associated infections (HAIs) - The growing cases of healthcare-associated BSI (HA-BSI) have been recorded in the last few years and the major cause of this disease is the use of intravascular catheters.
  As per a recent report, developed countries have shown that hospital-acquired blood infections (HA-BSIs) are one of the most serious nosocomial infections and constitute 20%–60% of hospitalization-related deaths. These infections have profound health implications for affected individuals. Hospitals and clinical diagnostics laboratories have a high demand for advanced products to detect these infections more precisely.

Challenges

• Restricted access to advanced healthcare facilities - People living in remote or rural locations majorly lack access to proper medical facilities, such as labs with advanced diagnostic equipment. Due to the physical distance to these facilities, it becomes very difficult for patients to get fast and accurate bloodstream infections.
  Various factors such as insufficient roads
• High maintenance and initial setup costs - A notable amount is needed to set up an advanced bloodstream infection testing infrastructure and equipment. The cost linked with these technologies restricts small healthcare facilities and areas from setting up such laboratories.
  Moreover, the expenses required for operation and maintenance including staff, equipment calibration, and training healthcare professionals create pressure on healthcare providers' finances after the initial setup, which hinders the market growth of bloodstream infection testing.